Positions

Overview

  • Ellen Eaton, MD, is an Associate Professor in the Department of Medicine and Division of Infectious Diseases. Her research and patient care centers on infectious consequences of substance use and mental illness. Her lab is developing and testing interventions to link patients to addiction treatment and prevention across the HIV care continuum in both acute care and community-based settings. Ellen is the Director of the Office Based Opioid Treatment Clinic at the 1917 HIV Clinic and a member of the leadership team at UAB's Center for Addiction and Pain Prevention Intervention. She is the Chair of the IDSA Grants for Emerging Investigator's (GERM) Program and a member of the IDSA/HIVMA Opioid Working Group.
  • Selected Publications

    Academic Article

    Year Title Altmetric
    2023 Physicians’ experiences with buprenorphine: A qualitative study of motivations for becoming X waivered and barriers to and facilitators of prescribing the medication for opioid use disorderDrug and Alcohol Dependence.  244. 2023
    2023 Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2022 Recommendations of the International Antiviral Society-USA PanelJournal of the American Medical Association.  329:63-84. 2023
    2022 Expanding access to substance use services and mental health care for people with HIV in Alabama, a technology readiness assessment using a mixed methods approachBMC Health Services Research.  22. 2022
    2022 Intersecting epidemics: The impact of coronavirus disease 2019 on the HIV prevention and care continua in the United StatesAIDS.  36:1749-1759. 2022
    2022 Vaccine Hesitancy versus Vaccine Behavior in Patients with Chronic IllnessJournal of Health Care for the Poor and Underserved.  33:2007-2031. 2022
    2022 Human Immunodeficiency Virus/Sexually Transmitted Infection Testing Preferences for Young Black Men Who Have Sex with Men in the Southeastern United States: Implications for a Post-COVID-19 EraSexually Transmitted Diseases.  49:208-215. 2022
    2022 Safer in care: A pandemic-tested model of integrated HIV/OUD careDrug and Alcohol Dependence.  231. 2022
    2022 Health care professional perspectives on discharging hospitalized patients with injection drug use-associated infectionsTherapeutic Advances in Infectious Disease.  9. 2022
    2022 Surgeons’ Perspectives on Valve Surgery in People With Drug Use-Associated Infective EndocarditisAnnals of Thoracic Surgery2022
    2021 Opioid use disorder: a neglected human immunodeficiency virus risk in American adolescentsAIDS.  35:2237-2247. 2021
    2021 Transportability from Randomized Trials to Clinical Care: On Initial HIV Treatment with Efavirenz and Suicidal Thoughts or BehaviorsAmerican Journal of Epidemiology.  190:2075-2084. 2021
    2021 We Thought We Created a Safety Net. We Were WrongClinical Infectious Diseases.  73:E1658-E1660. 2021
    2021 A Systematic Review of Opioid Use Disorder and Related BiomarkersFrontiers in Psychiatry.  12. 2021
    2021 Wave the Yellow Flag: Why We Should Prioritize Routine Human Immunodeficiency Virus and Sexually Transmitted Infection Care NowJournal of Infectious Diseases.  223:930-932. 2021
    2021 "rapid Start" Treatment to End the (Other) Epidemic: Walking the Tightrope without a NetClinical Infectious Diseases.  72:479-481. 2021
    2021 Web Exclusive. Annals On Call - Trends in Endocarditis Associated With Injection of Illicit DrugsACP journal club.  174:OC1. 2021
    2020 Substantial decline in heavily treated therapy-experienced persons with HIV with limited antiretroviral treatment optionsAIDS.  34:2051-2059. 2020
    2020 An integrated hospital protocol for persons with injection-related infections may increase medications for opioid use disorder use but challenges remainJournal of Infectious Diseases.  222:S499-S505. 2020
    2020 Management of Opioid Use Disorder and Infectious Disease in the Inpatient SettingInfectious Disease Clinics of North America.  34:511-524. 2020
    2020 In-Hospital illicit drug use and patient-directed discharge: Barriers to care for patients with injection-related infectionsOpen Forum Infectious Diseases.  7. 2020
    2020 Sexually transmitted infections and sexual behaviors of men who have sex with men in an American Deep South PrEP clinicInternational Journal of STD and AIDS.  31:127-135. 2020
    2020 Beyond antibiotics: A practical guide for the infectious disease physician to treat opioid use disorder in the setting of associated infectious diseasesOpen Forum Infectious Diseases.  7. 2020
    2020 Quantitative evaluation on the challenges and opportunities in the recruitment of young Black men who have sex with men for sexual health research in the southern USSexual Health.  17:87-90. 2020
    2019 Brief Report: Kidney Dysfunction Does Not Contribute Significantly to Antiretroviral Therapy Modification in Treatment-Naive PLWH Receiving Initial ART 2019
    2019 A 9-Point Risk Assessment for Patients Who Inject Drugs and Require Intravenous Antibiotics: Focusing Inpatient Resources on Patients at Greatest Risk of Ongoing Drug UseClinical Infectious Diseases.  68:1041-1043. 2019
    2019 Incidence and predictors of reinfection with trichomoniasis based on nucleic acid amplification testing results in HIV-infected patientsInternational Journal of STD and AIDS.  30:344-352. 2019
    2018 Do young black men who have sex with men in the deep south prefer traditional over alternative STI testing?PLoS One.  13. 2018
    2018 Psychosocial stressors and sexual health among Southern African American women who have sex with womenLGBT Health.  5:234-241. 2018
    2018 Reverse syphilis screening algorithm fails to demonstrate cost effectiveness in persons living with HIVInternational Journal of STD and AIDS.  29:563-567. 2018
    2018 Potential kidney toxicity from the antiviral drug tenofovir: New indications, new formulations, and a new prodrugCurrent Opinion in Nephrology and Hypertension.  27:102-112. 2018
    2018 Trends in antiretroviral therapy prescription, durability and modification: New drugs, more changes, but less failureAIDS.  32:347-355. 2018
    2018 Mental health service utilization is associated with retention in care among persons living with HIV at a university-affiliated HIV clinicAIDS Research and Therapy.  15. 2018
    2018 Patterns of efavirenz use as first-line antiretroviral therapy in the United States: 1999-2015Antiviral Therapy.  23:363-372. 2018
    2017 Patient preferences for antiretroviral therapy: Effectiveness, quality of life, access and novel delivery methodsPatient Preference and Adherence.  11:1585-1590. 2017
    2017 Antiretroviral therapy initiation and changes in self-reported depressionClinical Infectious Diseases.  64:1791-1794. 2017
    2017 Budgetary impact of compliance with sti screening guidelines in persons living with HIV 2017
    2017 The relationship between efavirenz as initial antiretroviral therapy and suicidal thoughts among HIV-infected adults in routine care 2017
    2016 Editorial Commentary: Affordable Care Act, Medicaid Expansion ... or Not: Ryan White Care Act Remains Essential for Access and EquityClinical Infectious Diseases.  63:404-406. 2016
    2016 Unanticipated effects of new drug availability on antiretroviral durability: Implications for comparative effectiveness researchOpen Forum Infectious Diseases.  3. 2016
    2016 Cost considerations in the current antiretroviral eraAIDS.  30:2215-2219. 2016
    2015 Immunization costs and programmatic barriers at an urban HIV clinicClinical Infectious Diseases.  61:1726-1731. 2015
    2014 Barrier Methods for Human Immunodeficiency Virus PreventionInfectious Disease Clinics of North America.  28:585-599. 2014
    2014 Engagement in human immunodeficiency virus care: Linkage, retention, and antiretroviral therapy adherenceInfectious Disease Clinics of North America.  28:355-369. 2014
    2012 Profound neurotoxicity and treatment response following one cycle of bortezomib therapy in an elderly male with multiple myelomaThe Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians.  28:193-196. 2012
    2011 West Nile virus encephalitis acquired via liver transplantation and clinical response to intravenous immunoglobulin: Case report and review of the literatureTransplant Infectious Disease.  13:312-317. 2011

    Principal Investigator On

  • Acceptable Multi-User Biodegradable Extended Release (AMBER) Implant System for HIV Prevention  awarded by RTI INTERNATIONAL
  • Eaton Omenn Fellowship  awarded by NATIONAL ACADEMY OF MEDICINE
  • HIV+ Service Delivery and Telemedicine Through Effective PROs  awarded by National Institute of Mental Health/NIH/DHHS
  • Investigating The Relationship between Chronic Pain and HIV Outcomes  awarded by University of Pittsburgh The
  • Private Grant  awarded by Gilead Sciences ^
  • Project LEAP (Linkage, Education, and Prevention): Integrating a Prevention Navigator to Reduce Substance Use and HIV Risk in Minority Youth  awarded by Substance Abuse & Mental Health Services Administration
  • The JCDH COVID-19 Special Population Project  awarded by JEFFERSON COUNTY BOARD OF HEALTH
  • UAB Center for AIDS Research (CFAR) - CFAR Supplement - Telemedicine to Integrate Substance Use and HIV Care Delivery for Persons who Inject Drugs in Alabama (TISH Study)  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS
  • UAB Center for AIDS Research - CFAR Supplement - Continuum of Care in Hospitalized Patients with Opioid Use Disorder (OUD) and Infectious Complications of Drug Use (CHOICE)  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS
  • Understanding Patients' and Providers' Experience Around OUD Treatment in Alabama  awarded by Pew Charitable Trusts
  • Zambia Alabama HIV Alcohol Comorbidities Program (ZAMBAMA) - TALC  awarded by National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS
  • Investigator On

  • A-Z Clinical Trials Unit  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS
  • ADVANCING ALSTATE (Alabama Lifespan Sickle cell Tracking Access Towards Equality) Network  awarded by CDC - Centers for Disease Control and Prevention/DHHS
  • ALSTATE (Alabama Lifespan Sickle Cell Tracking Access Towards Equality) Network  awarded by ALABAMA DEPARTMENT OF PUBLIC HEALTH
  • Addiction, Infection, and Immunology/Research: A CAPPI Research Program  awarded by UNIVERSITY OF ALABAMA HEALTH SERVICES FOUNDATION
  • Case Investigation, Contact Tracing, and Active Monitoring for the COVID-19  awarded by ALABAMA DEPARTMENT OF PUBLIC HEALTH
  • DETECT-HIV - Discovering Emerging Trends through Enhanced Community Testing for HIV Infection  awarded by ALABAMA DEPARTMENT OF PUBLIC HEALTH
  • DETECT-HIV - Discovering Emerging Trends through Enhanced Community Testing for HIV infection  awarded by ALABAMA DEPARTMENT OF PUBLIC HEALTH
  • DETECT-HIV – Discovering Emerging Trends through Enhanced Community Testing for HIV Infection  awarded by ALABAMA DEPARTMENT OF PUBLIC HEALTH
  • Effectiveness of a Smoking Cessation Algorithm Integrated into HIV Primary Care  awarded by National Institute on Drug Abuse/NIH/DHHS
  • Integrated HIV Surveillance and Prevention Programs for Health Departments  awarded by ALABAMA DEPARTMENT OF PUBLIC HEALTH
  • Integrated HIV Surveillance and Prevention Programs for Health Departments  awarded by ALABAMA DEPARTMENT OF PUBLIC HEALTH
  • Integrated HIV Surveillance and Prevention Programs for Health Departments  awarded by ALABAMA DEPARTMENT OF PUBLIC HEALTH
  • National Center for HIV-AIDS, Viral Hepatitis, STD, and TB Prevention Integrated HIV Surveillance and Prevention Programs for Health Departments  awarded by ALABAMA DEPARTMENT OF PUBLIC HEALTH
  • Opioid Use Disorder Center of Excellence  awarded by ALABAMA DEPARTMENT OF MENTAL HEALTH
  • Opioid Use Disorder Information Exchange  awarded by ALABAMA DEPARTMENT OF MENTAL HEALTH
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY
  • Private Grant  awarded by GlaxoSmithKline
  • Rectal and Oropharyngeal Swabs to Diagnose Gonococcal and Chlamydial Infection in Men and Women  awarded by University of California, San Francisco
  • Strategic Plans to Combat Opioid Use Disorder in the State of Alabama  awarded by FOUNDATION FOR OPIOID RESPONSE EFFORTS (FORE) ^
  • UAB Center for AIDS Research (CFAR)  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS
  • UAB Center for AIDS Research (CFAR)  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS
  • Zambia Alabama HIV Alcohol Comorbidities Program (ZAMBAMA)  awarded by National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS
  • Education And Training

  • Stanford University Medical Center, Residency
  • Stanford University Medical Center, Residency
  • UAB, Postdoctoral Fellowship
  • Master of Public Health, University of Alabama at Birmingham 2017
  • Doctor of Medicine in Internal Medicine Residency Program, University of Alabama at Birmingham 2007
  • Bachelor's Degree in Chemistry, Vanderbilt University 2003
  • Full Name

  • Ellen Eaton